Tag: ESPR Shares

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Esperion Therapeutics Inc.’s current trading price is -8.86% away from its 52-week high, while its distance from the 52-week low is 342.70%. The stock’s price range for this time frame has been between $0.70 and $3.40. The trading volume of the company’s shares in the Healthcare reached around 3.79 million for the day, which was evidently lower than the average daily volume of 6.72 million over the last three months. In terms of market performance, Esperion Therapeutics Inc. had

The market performance of Esperion Therapeutics Inc.’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $3.34 on 01/12/24, while the lowest value for the same duration was $0.70 on 10/12/23. 52-week price history of ESPR Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Esperion Therapeutics Inc.’s current trading price is -21.44% away from its 52-week high, while its distance from the 52-week low is 274.29%. The stock’s price range during this period has spanned from $0.70 to $3.34. In

Esperion Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $4.59 on 03/14/23, while the lowest price during the same period was $0.70 on 10/12/23. 52-week price history of ESPR Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Esperion Therapeutics Inc.’s current trading price is -52.29% away from its 52-week high, while its distance from the 52-week low is 212.86%. The stock’s price range for

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price loss of -21.91% this year. Over the last six months, there has been a weaker performance of 62.15%. The price of ESPR leaped by -9.50% during the last 30 days period. For the last 5-days stocks have slided -6.97%. Esperion Therapeutics Inc. experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year